Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 20/20 | 1.00 |
| ▸ | PDE4A | P27815 | 18/20 | 1.00 |
| ▸ | PDE4B | Q07343 | 18/20 | 1.00 |
| ▸ | PDE4C | Q08493 | 18/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6592230 | 1.00 | PDE4D (1.00) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL6586374 | 0.86 | PDE4A (0.75) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL6586372 | 0.86 | PDE4A (0.75) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL6586630 | 0.84 | PDE4A (0.72) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL6586625 | 0.84 | PDE4A (0.72) | PDE4DPDE4APDE4BPDE4C | |
| Hydrochloric Acid SCHEMBL6590136 | 0.82 | PDE4D (0.98) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL6586601 | 0.80 | PDE4D (1.00) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL6586660 | 0.78 | PDE4D (1.00) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL8344691 | 0.76 | PDE4A (0.71) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL6592499 | 0.76 | PDE4D (0.77) | PDE4DPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1097142-B1 | PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS | ZAMBON SPA (IT) | 2004-10-13 | — | — | EP | disclosed |
| US-6492360-B1 | Phthalazine derivatives phosphodiesterase 4 inhibitors | ZAMBON GROUP S.P.A. (IT) | 2002-12-10 | — | — | US | disclosed |
| US-6329370-B1 | CARDIOVASCULAR DISORDERS AND TUMOR NECROSIS FACTOR (HEREINAFTER TNF.SUB..ALPHA.), A CYTOKINE WITH PRO-INFLAMMATORY ACTIVITY | ZAMBON GROUP S.P.A. (IT) | 2001-12-11 | — | — | US | disclosed |